Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company’s flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysis of biological material of patients using swabs, urine, and saliva. It also develops SNAAT chemistry for mutation detection in oncology. In addition, the company develops and commercializes tests used in the detection of viral infectious diseases and other areas. Genomtec S.A. was incorporated in 2008 and is based in Wroclaw, Poland.
Metrics to compare | GMTP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGMTPPeersSector | |
---|---|---|---|---|
P/E Ratio | −8.1x | −5.3x | −0.5x | |
PEG Ratio | 1.75 | −0.02 | 0.00 | |
Price/Book | 6.3x | 2.8x | 2.6x | |
Price / LTM Sales | 15,858.3x | 15.2x | 3.2x | |
Upside (Analyst Target) | - | 34.3% | 44.1% | |
Fair Value Upside | Unlock | 13.9% | 6.2% | Unlock |